- Home
- PR vs ICLR Comparison
PR vs ICLR Comparison
Compare PR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PR
- ICLR
- Stock Information
- Founded
- PR 2015
- ICLR 1990
- Country
- PR United States
- ICLR Ireland
- Employees
- PR N/A
- ICLR N/A
- Industry
- PR Oil & Gas Production
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- PR Energy
- ICLR Health Care
- Exchange
- PR Nasdaq
- ICLR Nasdaq
- Market Cap
- PR 9.5B
- ICLR 11.4B
- IPO Year
- PR 2016
- ICLR 1998
- Fundamental
- Price
- PR $12.60
- ICLR $130.28
- Analyst Decision
- PR Strong Buy
- ICLR Buy
- Analyst Count
- PR 16
- ICLR 12
- Target Price
- PR $18.53
- ICLR $204.18
- AVG Volume (30 Days)
- PR 10.2M
- ICLR 1.6M
- Earning Date
- PR 05-07-2025
- ICLR 07-23-2025
- Dividend Yield
- PR 4.76%
- ICLR N/A
- EPS Growth
- PR 39.99
- ICLR 11.53
- EPS
- PR 1.62
- ICLR 9.19
- Revenue
- PR $5,134,186,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- PR $8.10
- ICLR N/A
- Revenue Next Year
- PR $1.13
- ICLR $2.34
- P/E Ratio
- PR $7.77
- ICLR $14.18
- Revenue Growth
- PR 37.00
- ICLR N/A
- 52 Week Low
- PR $10.01
- ICLR $125.10
- 52 Week High
- PR $16.95
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- PR 47.05
- ICLR 39.23
- Support Level
- PR $12.51
- ICLR $125.10
- Resistance Level
- PR $13.00
- ICLR $132.96
- Average True Range (ATR)
- PR 0.31
- ICLR 4.34
- MACD
- PR -0.08
- ICLR 0.79
- Stochastic Oscillator
- PR 7.19
- ICLR 29.63
About PR Permian Resources Corporation
Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.